Bank of America
IMPL

Bank of America’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Bank of America’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$2 – 8047
2023
Q2 		$2 Hold
2
– – ﹤0.01% 7651
2023
Q1 		$2 Sell
2
-31
-94% -$74 ﹤0.01% 7724
2022
Q4 		$124 Sell
33
-175
-84% -$638 ﹤0.01% 7632
2022
Q3 		$1K Sell
208
-315
-60% -$2.41K ﹤0.01% 7723
2022
Q2 		$4K Sell
523
-14,385
-96% -$105K ﹤0.01% 7670
2022
Q1 		$95K Sell
14,908
-2,148
-13% -$16.2K ﹤0.01% 6894
2021
Q4 		$148K Buy
17,056
+11,485
+206% +$115K ﹤0.01% 6670
2021
Q3 		$68K Buy
5,571
+5,220
+1,487% +$75.8K ﹤0.01% 6905
2021
Q2 		$3K Buy
+351
New +$4.19K ﹤0.01% 7513

Other funds holding IMPL

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America's IMPL Position: Q3 2023 in Review

Bank of America sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q3 2023, closing a stake of 2 shares — an estimated $2 sold.

Bank of America first reported a position in IMPL in Q2 2021 and held it in 9 quarters. The position peaked at $148K in Q4 2021. 32 funds tracked by Wall St. Rank hold IMPL as of Q3 2023.

  • Bank of America reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bank of America sold 2 Impel Pharmaceuticals Inc. Common Stock shares in Q3 2023, an estimated $2.
  • Bank of America first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • Bank of America's Impel Pharmaceuticals Inc. Common Stock position peaked at $148K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.